Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

References

Page 1

	Year	Citations
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Rafael Lozano, Mohsen Naghavi, Kyle J Foreman, The Lancet	2012	14.1K
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study Karen L. Kotloff, James P. Nataro, William C. Blackwelder, The Lancet Diarrhoeal DiseasePediatric EpidemiologyGlobal HealthInfant NutritionInternational Health	2013	3.5K
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Karen L. Kotloff, Jonathan P. Winickoff, B Ivanoff, PubMed	1999	1.3K
Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development Sofie Livio, Nancy Strockbine, Sandra Panchalingam, Clinical Infectious Diseases	2014	373
Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study Jie Liu, Furqan Kabir, Jainaba Manneh, The Lancet Infectious Diseases Molecular Diagnostic TechniquesChildhood DiarrhoeaPathogenesisMulticentre StudyGastroenterology	2014	313
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults Dani Cohen, Shai Ashkenazi, Manfred S. Green, The Lancet VaccinationVaccine SafetyCross-protectionYoung AdultsEfficacy Trial	1997	258
Epidemiologic Patterns of Acute Diarrhea and Endemic Shigella Infections in Children in a Poor Periurban Setting in Santiago, Chile Catterina Ferreccio, Valeria Prado, A Ojeda, American Journal of Epidemiology	1991	214
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB Christiane Gerke, Anna Colucci, Carlo Giannelli, PLoS ONE EngineeringShigella Sonnei VaccineImmunologyImmunotherapyGeneralized Modules	2015	166
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children J H Passwell, Shai Ashkenazi, Yonit Banet-Levi, Vaccine Medicine1–4-Year-old Israeli ChildrenAge-related EfficacyPediatrics	2010	165
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis Dani Cohen, Manfred S. Green, Colin Block, Journal of Clinical Microbiology Humoral ResponseImmunologyHumoral Antilipopolysaccharide AntibodiesSerologic TestingImmunochemistry	1991	159

Page 1